FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...

Many people with depression and anxiety in the U.S. could benefit from medication but do not receive any treatment, ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...

Takeda is taking back the home license for a phase 3-ready depression drug as part of an amendment to its multi-asset ...

Plus RFK on agriculture, Scott Bessent on taxes and whether scientists can trust Tulsi Gabbard and Pete Hegseth.

Patrick Kennedy suggests Robert F. Kennedy Jr. would be open to use of addiction medications as well as "wellness farms" for ...

Best known for his segments on The One Show and being the son of Spandau Ballet star Martin Kemp and pop sensation Shirlie ...

Roman Kemp has shared an insight into his family life, revealing that he "upset" his mum Shirlie Kemp with a heartbreaking ...

The move expands access to the novel mental health treatment, which has shown rapid symptom improvement for the past few ...

Treatment with the highest dose of investigational injectable amycretin -- a unimolecular GLP-1 and amylin receptor agonist -- yielded a 22% weight loss after 36 weeks in a phase Ib/IIa trial, said ...

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) amended its agreement with Takeda Pharmaceutical Co Ltd (NYSE:TAK) to develop and commercialize osavampator (NBI-1065845/TAK-653). Under the amended ...